Abstract
The importance of vitamin and mineral supplementation for persons who have cystic fibrosis (CF) is well established. Prior to the widespread availability of newborn screening, symptoms of overt vitamin or mineral deficiencies often were initial signs indicative of the CF diagnosis. Low vitamin serum levels continue to be seen, but signs of overt deficiency are infrequent and descriptions often are published as case reports. The introduction of CF-specific multivitamin supplements coupled with improved pancreatic enzyme replacement therapy (PERT) has contributed to the reduction in the incidence and prevalence of deficiencies. First table lists the nutrient content of currently available CF-specific multivitamins with zinc. The content of CF-specific vitamins has evolved since their introduction over 20 years ago resulting in improvement of targeted micronutrient serum levels.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ramsey BW, Farrell PM, Pencharz P, The Consensus Committee. Nutritional assessment and management in cystic fibrosis: a consensus report. Am J Clin Nutr. 1992;55:108–16.
Borowitz D, Baker RD, Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2002;35:246–59.
Sinaasappel M, Stern M, Littlewood J, Wolfe S, Steinkamp G, Harry GM, Heijerman HGM, Robberecht E, Döring G. Nutrition in patients with cystic fibrosis: a European consensus. J Cyst Fibros. 2002;1:51–75.
Yankaskas JR, Marshall BC, Sufian B, Simon RH, Rodman D. Cystic fibrosis adult care: consensus conference report. Chest. 2004;125:1S–39.
Borowitz D, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA, Spear SL, Michel SH, Parad RB, White TB, Farrell PM, Marshall BC, Accurso FJ. Cystic fibrosis foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr. 2009;155:S73–93.
Australasian clinical practice guidelines for nutrition in cystic fibrosis. daa.asn.au/wp-content/uploads/2012/09/Guidelines_CF-Final.pdf. Accessed July 2014.
Nutritional management of cystic fibrosis. www.cysticfibrosis.org.uk/media/82052/nutritional-management-of-cystic-fibrosis-apr02.pdf. Accessed July 2014.
Farrell PM, Bieri JG, Fratononi JF, Wood RE, di Sant’Agnese PA. The occurrence and effects of human vitamin E deficiency-a study in patients with cystic fibrosis. J Clin Invest. 1977;60:233–41.
Palin D, Underwood BA, Denning CF. The effect of oral zinc supplementation on plasma levels of vitamin A and retinol-binding protein in cystic fibrosis. Am J Clin Nutr. 1979;32:1253–9.
Hubbard VS, Farrell PM, di Sant’Agnese PA. 25-Hydroxy cholecalciferol levels in patients with cystic fibrosis. J Pediatr. 1979;94:84–6.
Solomons NW, Wagonfield JB, Rieger C, Jacob RA, Bolt M, Horst JV, Rothberg R, Sandstead H. Some biochemical indices of nutrition in treated cystic fibrosis patients. Am J Clin Nutr. 1981;34:462–74.
Leung M, Bayliff CD, Patersn NA, Leggatt P. Night blindness secondary to vitamin A deficiency in a patient with cystic fibrosis and short gut syndrome. Can J Hosp Pharm. 2006;59(2):74–5.
Obeid M, Price J, Sun L, Scantlebury MH, Overby P, Sidhu R, et al. Facial palsy and idiopathic intracranial hypertension in twins with cystic fibrosis and hypovitaminosis A. Pediatr Neurol. 2011;44:150–2.
Rana M, Wong-See D, Katz T, Gaskin K, Whitehead B, Jaffe A, Coakley J, Lochhead A. Fat-soluble vitamin deficiency in children and adolescents with cystic fibrosis. J Clin Pathol. 2014;14(7):1–4. doi:10.1136/jclinpath-2013-201787.
Roddy MF, Greally P, Clancy G, Leen G, Feehan S, Elnazir B. Night blindness in a teenager with cystic fibrosis. Nutr Clin Pract. 2011;26:718–21.
Bertolaso C, Groleau V, Schall JI, Maqbool A, Mascarenhas M, Latham NE, Dougherty KA, Stallings VA. Fat-soluble vitamins in cystic fibrosis and pancreatic insufficiency: efficacy of a nutrition intervention. J Pediatr Gastroenterol Nutr. 2014;58(4):443–8.
Hollander FM, de Roos NM, Dopheide J, Hoekstra T, van Berkhout FT. Self-reported use of vitamins and other nutritional supplements in adult patients with cystic fibrosis. Is daily practice in concordance with recommendations? Int J Vitam Nutr Res. 2010;80(6):408–15.
Palmery M, Saraceno A, Vaiarelli A, Carlomagno G. Oral contraceptives and changes in nutritional requirements. Eur Rev Med Pharmacol Sci. 2013;17:1804–13.
Siwamogsatham O, Dong W, Binongo JN, Chowdhury R, Alvarez JA, Feinman SJ, Enders J, Tangpricha V. Relationship between fat-soluble vitamin supplementation and blood concentrations in adolescent and adult patients with cystic fibrosis. Nutr Clin Pract. 2014;29:491–7.
Wilson SMC, Bivins BN, Russell KA, Bailey LB. Oral contraceptive use: impact on folate, vitamin B6 and vitamin B12 status. Nutr Rev. 2011;69:572–83.
Lancellotti L, D’Orazio C, Mastella G, Mazzi G, Lippi U. Deficiency of vitamins E and A in cystic fibrosis is independent of pancreatic function and current enzyme and vitamin supplementation. Eur J Pediatr. 1996;155:281–5.
Hakim F, Kerem E, Rivlin J, Bentur L, Stankiewicz H, Bdolach-Abram T, Wilschanski M. Vitamins A and E and pulmonary exacerbations in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2007;45:347–53.
Sokol RJ, Reardon MC, Accurso FJ, Stall C, Narkewicz M, Abman SH, Hammond KB. Fat-soluble-vitamin status during the first year of life in infants with cystic fibrosis identified by screening of newborns. Am J Clin Nutr. 1989;50:1064–71.
Krebs NF, Sontag M, Accurso FJ, Hambidge KM. Low plasma zinc concentrations in young infants with cystic fibrosis. J Pediatr. 1998;133:761–4.
Feranchak AP, Sontag MK, Wagerer JS, Hammond KB, Accurso FJ, Sokol RJ. Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen. J Pediatr. 1999;135:601–10.
Easley D, Krebs N, Jefferson M, Miller L, Erskine J, Accurso F, Hambidge KM. Effect of pancreatic enzymes on zinc absorption in cystic fibrosis. J Pediatr Gastroenterol Nutr. 1998;26:136–9.
Cantin AM, White TB, Cross CE, Forman HJ, Sokol RJ. Borowitz. Antioxidants in cystic fibrosis: conclusions from the CF antioxidant workshop, Bethesda, Maryland, November 11–12, 2003. Free Radic Biol Med. 2007;42:15–31.
Shamseer L, Adams D, Brown N, Johnson JA, Vohra S. Antioxidant micronutrients for lung disease in cystic fibrosis. Cochrane Database Syst Rev. 2010;12, CD007020.
Tinley CG, Withers NJ, Sheldon CD, Quinn AG, Jackson AA. Zinc therapy for night blindness in cystic fibrosis. J Cyst Fibros. 2008;7:333–335.
Vitamin A
James DR, Owen G, Campbell IA, Goodchild MC. Vitamin A absorption in cystic fibrosis: risk of hypervitaminosis A. Gut. 1992;33:707–10.
Maqbool A, Dougherty K, Rovner AJ, Michel S, Stallings VA. Nutrition. In: Allen JL, Panitch HB, Rubenstein RC, editors. Nutrition. New York: Informa healthcare; 2010. p. 308–27.
Institute of Medicine. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium and zinc. Washington: National Academy Press, 2001. p 82–161.
Michaëlsson K, Lithell H, Vessby B, Melhus H. Serum retinol levels and the risk of fracture. N Engl J Med. 2003;348:287–94.
Huet F, Semama DM, Maingueneau C, Charavel A, Nivelon JL. Vitamin A deficiency and nocturnal vision in teenagers with cystic fibrosis. Eur J Pediatr. 1997;156:949–51.
Schupp C, Olano-Martin E, Gerth C, Morrissey BM, Cross CE, Werner JS. Lutein, zeazanthin, macular pigment, and visual function in adult cystic fibrosis patients. Am J Clin Nutr. 2004;79:1045–52.
Greer RM, Buntain HM, Lewindon PJ, Wainwright CE, Potter JM, Wong JC, Francis PW, Batch JA, Bell SC. Vitamin A levels in patients with CF are influenced by the inflammatory response. J Cyst Fibros. 2004;3:143–9.
Aird FK, Greene SA, Ogston SA, Macdonald TM, Mukhopadhyay S. Vitamin A and lung function in CF. J Cyst Fibros. 2006;5:129–31.
Rivas-Crespo MR, Jiménez DG, Acuña Quirós MD, Aguirre AS, González SH, Martin JJD, Otero JMG, Almarza AL, Bousoño-Garcia C. High serum retinol and lung function in young patient with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2013;56(6):657–62.
Bines JE, Truby HD, Armstrong DS, Carzino R, Grimwoood K. Vitamin A and E deficiency and lung disease in infants with cystic fibrosis. J Paediatr Child Health. 2005;41:663–8.
Bonifant CM, Shevill E, Chang AB. Vitamin A supplementation for cystic fibrosis. Cochrane Database Syst Rev. 2014;(5): CDoo6751.
Krause’s food & the nutrition care process. 13th ed. In: Mahan LK, Escott-Stump S, Raymond JL, editors. Elsevier Saunders, St Louis, Missouri, 2012. p 1089–94.
Brei C, Simon A, Krawinkel MB, Naehrlich L. Individualized vitamin A supplementation for patients with cystic fibrosis. Clin Nutr. 2013;32:805–10.
Graham-Maar RC, Schall JI, Stettler N, Zemel BS, Stallings VA. Elevated vitamin A intake and serum retinol in preadolescent children with cystic fibrosis. Am J Clin Nutr. 2006;84:174–82.
Maqbool A, Graham-Maar RC, Schall JI, Zemel BS, Stallings VA. Vitamin A intake and elevated serum retinol levels in children and young adults with cystic fibrosis. J Cyst Fibros. 2008;7:137–41.
World Health Organization. Vitamin A dosage during pregnancy and lactation: recommendations and report of a consultation. 1998. Document NUT/98.4.
Ho T, Gupta S, Brotherwood M, Robert R, Cortes D, Verjee Z, Tullis E, Keshavjee S, Chaparro C, Stephenson A. Increased vitamin A and E levels after lung transplant. Transplantation. 2011;92:601–6.
Vitamin E
Farrell PM, Mischler EH, Gutcher G. Evaluation of vitamin E deficiency in children with lung disease. Ann N Y Acad Sci. 1982;393:96–106.
Cynamon HA, Milov DE, Valenstein E, Wagner M. Effect of vitamin E deficiency on neurologic function in patients with cystic fibrosis. J Pediatr. 1988;113:637–40.
Sokol RJ, Butler-Simon N, Heubi JE, Iannaccone ST, McClung HJ, Accurso F, Hammond K, Heyman M, Sinatra F, Riely C, Perrault J, Levy J, Siverman A. Vitamin E deficiency neuropathy in children with fat malabsorption. Studies in cystic fibrosis and chronic cholestasis. Ann N Y Acad Sci. 1989;570:156–69.
Sitrin MD, Lieberman F, Jensen WE, Noronha A, Milburn C, Addington W. Vitamin E deficiency and neurologic disease in adults with cystic fibrosis. Ann Intern Med. 1987;107:51–4.
Chakrabarty B, Kabra SK, Gulati S, Toteja GS, Lodha R, Kabra M, Pandey RM, Srivastava A. Peripheral neuropathy in cystic fibrosis: a prevalence study. J Cyst Fibros. 2013;12:754–60.
Kelleher J, Miller MG, Littlewood JM, McDonald AM, Losowsky MS. The clinical effect of correction of vitamin E depletion in cystic fibrosis. Int J Vitam Nutr Res. 1987;57:253–9.
Leonard DH, Roos-Wilson C, Smyth AR, Polnay J, Range SP, Knowx AJ. A study of a single high potency multivitamin preparation in the management of cystic fibrosis. J Hum Nutr Diet. 1998;11:490–500.
Huang SH, Schall JI, Zemel BS, Stallings VA. Vitamin E status in children with cystic fibrosis and pancreatic insufficiency. J Pediatr. 2006;148:556–9.
Van Biervliet S, Vanbillemont G, Van Biervliet JP, Declercq D, Robberecht E, Christophe A. Relation between fatty acid composition and clinical status or genotype in cystic fibrosis patients. Ann Nutr Metab. 2007;51:541–9.
Van Biervliet BS, Devos M, Delhaye T, Van Biervliet JP, Robberecht E, Christophe A. Oral DHA supplementation in delta F508 homozygous cystic fibrosis patients. Prostaglandins Leukot Essent Fatty Acids. 2008;78:109–15.
Wood LG, Gitzgerald DA, Garg ML. Hypothesis: vitamin E complements polyunsaturated fatty acids in essential fatty acid deficiency in cystic fibrosis. J Am Coll Nutr. 2003;22:253–7.
Kosick RL, Lai HC, Laxova A, Zaremba KM, Losorok MR, Douglas JA, Rock MJ, Splaingard ML, Farrell PM. Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening. J Pediatr. 2005;147:S51–6.
Oudshoorn JH, Klijn PH, Hofman Z, Voorbji HA, van der Ent CK, Berger R, Houwen RH. Dietary supplementation with multiple micronutrients: no beneficial effects in pediatric cystic fibrosis patients. J Cyst Fibros. 2007;6:35–40.
Booth SL, Golly I, Sacheck JM, Roubenoff R, Dallal GE, Hamada K, Blumberg JB. Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status. Am J Clin Nutr. 2004;80(1):143–8.
Institute of Medicine. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington: National Academy Press; 2000.
Chin KY, Ima-Nirwana S. The effects of alpha-tocopherol on bone: a double-edged sword? Nutrients. 2014;6:1424–41.
Nasir SZ, O’Leary H, Hillermeier C. Correction of vitamin E deficiency with fat-soluble versus water-miscible preparations of vitamin E in patients with cystic fibrosis. J Pediatr. 1993;122:810–2.
Winklhofer-Roob BM, van’t Hof MA, Shmerling DH. Long-term oral vitamin E supplementation in cystic fibrosis patients: RRR-alpha-tocopherol compared with all-rac-alpha-tocopheryl acetate preparations. Am J Clin Nutr. 1996;63(5):722–8.
Soltani-Frisk S, Gronowitz E, Andersson H, Strandvik B. Water-miscible tocopherol is not superior to fat-soluble preparation for vitamin E absorption in cystic fibrosis. Acta Paediatr. 2001;90(10):1112–5.
Back EI, Frindt C, Ocenaskova E, Nohr D, Stern M, Biesalski HK. Can changes in hydrophobicity increase the bioavailability of alpha-tocopherol? Eur J Nutr. 2006;45:1–6.
Papas K, Kalbfleisch J, Mohon R. Bioavailability of a novel, water-soluble vitamin E formulation in malabsorbing patients. Dig Dis Sci. 2007;52:347–52.
Sokol RJ, Heubi JE, Iannaccone ST, Bove KE, Balistreri WF. Vitamin E deficiency with normal serum vitamin E concentrations in children with chronic cholestasis. N Engl J Med. 1984;310:1209–12.
Sokol R. Selection bias and vitamin E status in cystic fibrosis. J Pediatr. 2007;150(5):e85–6.
James DR, Alfaham M, Goodchild MC. Increased susceptibility to peroxide-induced haemolysis with normal vitamin E concentrations in cystic fibrosis. Clin Chim Acta. 1991;204:279–90.
Vitamin K
Dam H. The antihaemorrhagic vitamin of the chick. Biochemistry. 1935;29:1273–85.
Nelsestuen GL, Zytkovica TH, Howard JB. The mode of action of vitamin K. Identification of gamma-carboxyglutamic acid as a component of protrombin. J Biol Chem. 1974;249:6347–50.
Michel SH, Maqbool A, Hanna MD, Mascarenhas M. Nutrition management of pediatric patients who have cystic fibrosis. Pediatr Clin N Am. 2009;56:1123–41.
Alexander G, Suttie J. The effects of vitamin E on vitamin K activity. FASEB J. 1999;13:A535.
Shwachman H. Therapy of cystic fibrosis of the pancreas. Pediatrics. 1960;25:155–63.
Di Sant’Agnese P, Vidaurreta A. Cystic fibrosis of the pancreas. J Am Med Assoc. 1960;172:2065–72.
Torstenson OL, Humphrey GB, Edson JR, Warwick WJ. Cystic fibrosis presenting with severe hemorrhage due to vitamin K malabsorption: a report of 3 cases. Pediatrics. 1970;45:857–61.
Walters TR, Koch HF. Haemorrhagic diathesis and cystic fibrosis in infancy. Am J Dis Child. 1972;124:641–2.
Hamid B, Khan A. Cerebral hemorrhage as the initial manifestation of cystic fibrosis. J Child Neurol. 2007;22:114–5.
Verghese T, Beverley D. Vitamin K deficient bleeding in cystic fibrosis. Arch Dis Child. 2003;88:553–5.
Ngo B, Van Pelt K, Labarque V, Van De Casseye W, Penders J. Late vitamin K deficiency bleeding leading to a diagnosis of cystic fibrosis: a case report. Acta Clin Belg. 2011;66(2):142–3.
Rashid M, Durie P, Andrew M, Kalnins D, Shin J, Corey M, Tullis E, Pencharz PB. Prevalence of vitamin K deficiency in cystic fibrosis. Am J Clin Nutr. 1999;70:378–82.
Beker LT, Ahrens RA, Fink RJ, O’Brien ME, Davidson KW, Sokoll LJ, Sadowski JA. Effect of vitamin K1 supplementation on vitamin K status in cystic fibrosis patients. J Pediatr Gastroenterol Nutr. 1997;24:512–7.
Conway SP, Wolfe SP, Brownlee KG, White H, Oldroyd B, Truscott JG, Harvey JM, Shearer MJ. Vitamin K status among children with cystic fibrosis and its relationship to bone mineral density and bone turnover. Pediatrics. 2005;115:1325–31.
Nicolaidou P, Stavrinadis I, Loukou I, Papadopoulou A, Georgouli H, Douros K, Priftis KN, Gourgiotis D, Matsinos YG, Doudounakis S. The effect of vitamin K supplementation on biochemical markers of bone formation in children and adolescents with cystic fibrosis. Eur J Pediatr. 2006;165:540–5.
Fewtrell MS, Benden C, Williams JE, Chomtho S, Ginty F, Nigdikar SV, Jaffe A. Undercarboxylated osteocalcin and bone mass in 8–12 year old children with cystic fibrosis. J Cyst Fibros. 2008;7:307–12.
Mosler K, von Kries R, Vermeer C, Saupe J, Schmitz T, Schoster A. Assessment of vitamin K deficiency in CF-how much sophistication is useful? J Cyst Fibros. 2003;2:91–6.
Wilson DC, Rashid M, Durie PR, Tsang A, Kalnins D, Andrew M, Corey M, Shin J, Tullis E, Pencharz PB. Treatment of vitamin K deficiency in cystic fibrosis: effectiveness of a daily fat-soluble vitamin combination. J Pediatr. 2001;138:851–5.
van Hoorn JH, Hendriks JJ, Vermeer C, Forgot PP. Vitamin K supplementation in cystic fibrosis. Arch Dis Child. 2003;88:974–5.
Drury D, Grey VL, Ferland G, Gunberg C, Lands LC. Efficacy of high dose phylloquinone in correcting vitamin K deficiency in cystic fibrosis. J Cyst Fibros. 2008;7:457–9.
Dougherty KA, Schall JI, Stallings VA. Suboptimal vitamin K status despite supplementation in children and young adults with cystic fibrosis. Am J Clin Nutr. 2010;92:660–7.
Jagannath VA, Fedorowicz Z, Thaker V, Chang AB. Vitamin K supplementation for cystic fibrosis (Review). Cochrane Database Syst Rev. 2013;(4). CD008482.
Durie PR. Vitamin K, and the management of patients with cystic fibrosis. Can Med Assoc J. 1994;151:933–6.
Olsen RE. Vitamin K. In: Shils ME, Olson JA, Shike M, editors. Modern nutrition in health and disease. 8th ed. Baltimore: Williams and Wilkins; 1994. p. 343–58.
Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium and zinc. Washington: National Academy Press, 2001. p. 162–96.
Water-Soluble Vitamins
Carr SB, McBratney J. The role of vitamins in cystic fibrosis. J R Soc Med. 2000;93 Suppl 38:14–9.
McCabe H. Riboflavin deficiency in cystic fibrosis: three case reports. J Hum Nutr Diet. 2001;14:365–70.
Scambi C, DeFranceschi L, Gurini P, Poli F, Siciliano A, Pattini P, et al. Preliminary evidence for cell membrane amelioration in children with cystic fibrosis by 5-MTHF and vitamin B12 supplementation: a single arm trial. PLoS One. 2009;4, e4782.
Back EL, Frindt C, Nohr D, Frank J, Ziebach R, Stern M, Ranke M, Biesalski HK. Antioxidant deficiency in cystic fibrosis: when is the right time to take action. Am J Clin Nutr. 2004;80:374–84.
Sodium chloride
Leoni GB. A specific cystic fibrosis mutation (T3381) associated with phenotype of isolated hypotonic dehydration. J Pediatr. 1995;127:281–3.
Fustik S, Pop-Jordanova N, Slaveska N, Koceva S, Efremov G. Metabolic alkalosis with hypoelectrolytemia in infants with cystic fibrosis. Pediatr Int. 2002;44:289–92.
Yalcin E. Clinical features and treatment approaches in cystic fibrosis with pseudo-Bartter syndrome. Ann Trop Paediatr. 2005;25:119–24.
Laughlin JJ, Brady MS, Eigen H. Changing feeding trends as a cause of electrolyte depletion in infants with cystic fibrosis. Pediatrics. 1981;68:203–7.
Bar-Or O, Blimkie CJR. Voluntary dehydration and heat intolerance in cystic fibrosis. Lancet. 1992;339:696–9.
Scurati-Manzoni E, Fossali EF, Agostoni C, Riva E, Simonetti GD, Zanolari-Calderari M, Bianchetti MG, Lava SA. Electrolyte abnormalities in cystic fibrosis: systematic review of the literature. Pediatr Nephrol. 2014;29:1015–23.
Orenstein DM, Henke KG, Costill DL, Doershuk CF, Lemon PJ, Stern RC. Exercise and heat stress in cystic fibrosis patients. Pediatr Res. 1983;17:267–9.
Bower TR, Pringle KC, Soper RT. Sodium deficit causing decreased weight gain and metabolic acidosis in infants with ileostomy. J Pediatr Surg. 1988;23:567–72.
Coates AJ, Crofton PM, Marshall T. Evaluation of salt supplementation in CF infants. J Cyst Fibros. 2009;8:382–5.
Kriemler S, Wilk B, Schurer W, Wilson WM, Bar-Or O. Preventing voluntary dehydration in children with cystic fibrosis who exercise in the heat. Med Sci Sports Exerc. 1999;31:774–9.
Calcium
Schulze KJ, O’Brien KO, Germain-Lee EL, Baer DJ, Leonard AL, Rosenstein BJ. Efficiency of calcium absorption is not compromised in clinically stable prepubertal and pubertal girls with cystic fibrosis. Am J Clin Nutr. 2003;78:110–6.
Schulze KJ, O’Brien KO, Germain-Lee EL, Booth SL, Leonard AL, Rosenstein BJ. Calcium kinetics are altered in clinically stable girls with cystic fibrosis. J Clin Endocrinol Metab. 2004;89:3385–91.
Schulze KJ, O’Brien KO, Germain-Lee EL, Baer DJ, Leonard AL, Rosenstein BJ. Endogenous fecal losses of calcium compromise calcium balance in pancreatic-insufficient girls with cystic fibrosis. J Pediatr. 2003;143:765–71.
Schulze KJ, Cutchins C, Rosenstein BJ, Germain-Lee EL, Obrien KO. Calcium acquisition rates do not support age-appropriate gains I total body bone mineral content in prepuberty and late puberty in girls with cystic fibrosis. Osteoporos Int. 2006;17:731–40.
Hillman LS, Cassidy JT, Popescu MF, Hewett JE, Kyger J, Robertson JD. Percent true calcium absorption, mineral metabolism, and bone mineralization in children with cystic fibrosis: effect of supplementation with vitamin D and calcium. Pediatr Pulmonol. 2008;43:772–80.
Sermet-Gaudelus I, Bianchi ML, Garabédian M, Aris RM, Morton A, Hardin DS, Elkin SL, Compston JE, Conway SP, Castanet M, Wolfe S, Saworth CS. European cystic fibrosis bone mineralization guidelines. J Cyst Fibros. 2011;10 Suppl 10:16–23.
Aris RM, Merkel PA, Bachrach LK, Borowitz DS, Boyle MP, Elkin SL, Guise TA, Hardin DS, Haworth CS, Holick MF, Joseph PM, O’Biren K, Tullis E, Watts NB, White TB. Consensus statement: guide to bone health and disease in cystic fibrosis. J Clin Endocrinol Metab. 2005;90:1888–96.
Sorensen MD, Kahn AJ, Reiner AP, Tseng TY, Shikany JM, Wallace RB, Chi T, Wactawski-Wend J, Jackson RD, O’Sullivan MJ, Sadetshy N, Stoller ML, WHI Working Group. Impact of nutritional factors on incident kidney stone formation: a report from the WHI OS. J Urol. 2012;187:1645–49.
Magnesium
Hersh T, Siddiqui DA. Magnesium and the pancreas. Am J Clin Nutr. 1973;26:362–6.
Saris NEL, Mervaala E, Karppanen H, Khawaja JÁ, Lewenstam A. Magnesium: an update on physiological, clinical and analytical aspects. Clin Chim Acta. 2000;294:1–26.
Sanders NN, Franckx H, DeBoeck K, Haustraete J, DeSmedt SC, Demeester J. Role of magnesium in the failure of rhDNase therapy in patients with cystic fibrosis. Thorax. 2006;61:962–8.
Gontijo-Amaral C, Guimarães EV, Camargos P. Oral magnesium supplementation in children with cystic fibrosis improves clinical and functional variables: a double-blind, randomized, placebo-controlled crossover trial. Am J Clin Nutr. 2012;96:50–6.
Atsmon J, Dolev E. Drug-induced hypomagnesaemia: scope and management. Drug Saf. 2005;28:763–88.
Zinc
Prasad AS. Zinc deficiency in women, infants, and children. J Am Coll Nutr. 1996;15:113–20.
Damphousse V, Mailhot M, Berthiaume Y, Rabasa-Lhoret R, Mailhot G. Plasma zinc in adults with cystic fibrosis: correlations with clinical outcomes. J Trace Elem Med Biol. 2014;28:60–4.
Krebs NF. Overview of zinc absorption and excretion in the human gastrointestinal tract. J Nutr. 2000;130 Suppl 5:1374–7.
Krebs NF, Westcott JE, Arnold TD, Kluger BM, Accurso FJ, Miller LV, Hambidge KM. Abnormalities in zinc homeostasis in young infants with cystic fibrosis. Pediatr Res. 2000;48:256–61.
Crone J, Huber WD, Eichler I, Granditsch G. Acrodermatitis enteropathica-like eruption as the presenting sign of cystic fibrosis and review of the literature. Eur J Pediatr. 2002;161:475–8.
Bernstein ML, McCusker MM, Grant-Kels JM. Cutaneous manifestations of cystic fibrosis. Pediatr Dermatol. 2008;25:150–7.
Abdulhamid I, Beck FW, Millard S, Chen X, Prasad A. Effect of zinc supplementation on respiratory tract infections in children with cystic fibrosis. Pediatr Pulmonol. 2008;43:281–7.
Van Biervliet S, Van Biervliet JP, Robberecht E. Serum zinc in patients with cystic fibrosis at diagnosis and after one year of therapy. Biol Trace Elem Res. 2006;112:205–11.
Van Biervliet S, VandeVelde S, Van Biervliet JP, Robberecht E. The effect of zinc supplements in cystic fibrosis patients. Ann Nutr Metab. 2008;52:152–6.
Ataee P, Najafi M, Gharagozlou M, Aflatounian M, Khodadad A, Farahmand F, Motamed F, Fallahi GH, Kalantari N, Soheili H, Modarresi V, Sabbaghian M, Rezaei N. Effect of supplementary zinc on body mass index, pulmonary function and hospitalization in children with cystic fibrosis. Turk J Pediatr. 2014;56:127–32.
Krebs NF. Update on zinc deficiency and excess in clinical pediatric practice. Ann Nutr Metab. 2013;62 Suppl 1:19–29.
Iron
Reid DW, Withers NJ, Francis L, Wilson JW, Kotsimbos TC. Iron deficiency in CF: relationship to lung disease severity and chronic pseudomonas aeruginosa infection. Chest. 2002;121:48–54.
Reid DW, Lam QT, Schneider H, Walter EH. Airway iron and iron-regulatory cytokines in CF. Eur Respir J. 2004;24:286–91.
Uljterschout L, Nuijsink M, Hendriks D, Rimke V, Brus F. Iron deficiency occurs frequently in children with cystic fibrosis. Pediatr Pulmonol. 2013;136:458–462.
Von Drygalski A, Biller J. Anemia in CF: incidence, mechanisms, and association with pulmonary function and vitamin deficiency. Nutr Clin Pract. 2008;23:557–63.
Keevil B, Rowlands D, Burton I, Webb AK. Assessment of iron status in cystic fibrosis patients. Ann Clin Biochem. 2000;37(Pt 5):662–5.
Fischer R, Simmerlein R, Huber RM, Schiffl H, Lang SM. Lung disease severity, chronic inflammation, iron deficiency and erythropoietin response in adults with CF. Pediatr Pulmonol. 2007;42:1193–7.
Hoo ZH, Wildman MJ. Regarding the article entitled “Iron supplementation does not worsen respiratory health or alter the sputum microbiome in cystic fibrosis.” J Cyst Fibros. 2014. doi:10.1016/j.jcf2014.06.002.
Gifford AH, Alexandru DM, Zhigang L, Dorman DB, Moulton LA, Price KE, Hampton TH, Sogin ML, Zuckerman JB, Parker HW, Stanton BA, O’Toole GA. Iron supplementation does not worsen respiratory health or alter the sputum microbiome in cystic fibrosis. J Cyst Fibros. 2014;13(30):311–8.
Hoo ZH, Wildman MJ. Intravenous iron among cystic fibrosis patients. J Cyst Fibros. 2012;11:560–2.
Uijterschout L, Swinkels DW, Akkermans MD, Zandstra T, Nuijsink M, Hendriks D, Hudig C, Tjalsma H, Vos R, van Goudoever JB, Brus F. The value of soluble transferrin receptor and hepcidin in the assessment of iron status in children with cystic fibrosis. J Cyst Fibros. 2014. doi:10.1016/j.jcf.2014.03.007.
Skikne BS, Punnonen K, Caldron PH, Bennett MT, Rehu M, Gasior GH, et al. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index. Am J Hematol. 2011;86(11):923–7.
Smith DJ, Anderson GJ, Lamont IL, Mael P, Bell SC, Reid DW. Accurate assessment of systemic iron status in cystic fibrosis will avoid the hazards of inappropriate iron supplementation. J Cyst Fibros. 2013;12:303–4.
Khalid S, McGrowder D, Kemp M, Johnson P. The use of soluble transferrin receptor to assess iron deficiency in adults with cystic fibrosis. Clin Chim Acta. 2007;378:194–200.
Selenium
Rayman MP. The importance of selenium to human health. Lancet. 2000;356:233–41.
Hubbard VS, Barbero G, Chase HP. Selenium and cystic fibrosis. J Pediatr. 1980;96:421–2.
Snodgrass W, Rumack BH, Sullivan Jr JB, Peterson RG, Chase HP, Cotton EK, Sokol R. Selenium: childhood poisoning and cystic fibrosis. Clin Toxicol. 1981;18:211–20.
MacFarquhar JK, Broussard DL, Melstrom P, Hutchinson R, Wolkin A, Martin C, Burk RF, Dunn JR, Green AL, Hammond R, Schaffner W, Jones TF. Acute selenium toxicity associate a dietary supplement. Arch Intern Med. 2010;170:256–61.
Winklhofer-Roob BM, Tiran B, Tuchschmid PE, van’t Hof MA, Shmerling DH. Effects of pancreatic enzyme preparations on erythrocyte glutathione peroxidase activities and plasma selenium concentrations in CF. Free Radical Biol Med. 1998;25:242–9.
Michalke B. Selenium speciation in human serum of cystic fibrosis patients compared to serum from healthy persons. J Chromatogr A. 2004;1058:203–8.
Portal B, Richard MJ, Coudray C, Arnaud J, Favier A. Effect of double-blind cross-over selenium supplementation on lipid peroxidation markers in cystic fibrosis patients. Clin Chim Acta. 1995;234:137–46.
Wood LG, Fitzgerald DA, Lee AK, Garg ML. Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function. Am J Clin Nutr. 2003;77:150–9.
Copper
Best K, McCoy K, Gemma S, DiSilvestro RA. Copper enzyme activities in cystic fibrosis before and after copper supplementation plus or minus zinc. Metabolism. 2004;53:37–41.
Percival SS, Bowser E, Wagner M. Reduced copper enzyme activities in blood cells of children with cystic fibrosis. Am J Clin Nutr. 1995;62:633–8.
Percival SS, Kauwell GPA, Bower E, Wagner M. Altered copper status in adult men with cystic fibrosis. J Am Coll Nutr. 1999;18:614–9.
Fluoride
Clark MB, Slayton RL, Section on Oral Health. Fluoride use in caries prevention in the primary care setting. Pediatrics. 2014;134:626–33.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Michel, S.H., Mueller, D.H. (2015). Vitamins and Minerals. In: Yen, E., Leonard, A. (eds) Nutrition in Cystic Fibrosis. Nutrition and Health. Humana Press, Cham. https://doi.org/10.1007/978-3-319-16387-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-16387-1_5
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-16386-4
Online ISBN: 978-3-319-16387-1
eBook Packages: MedicineMedicine (R0)